LEARN THE BASICS
One-time gains and losses: adjust with care
Find unusual items, understand where they appear, and avoid turning management’s adjusted metric into an unquestioned answer.
Unusual does not always mean nonrecurring
Restructuring, impairments, litigation, asset sales, and acquisition costs may be described as unusual, but similar costs can recur over time. Start with the reported GAAP result. Then identify the exact line, amount, tax effect, cash effect, and disclosure that supports any adjustment.
Location changes the story
A gain from selling an asset can raise pretax income while the related cash proceeds appear in investing cash flow. An impairment can lower income without a same-period cash payment. Stock compensation is noncash when recorded but can still affect ownership and future cash taxes. Classification matters as much as the label.
Reconcile management’s alternatives
When a company presents a non-GAAP measure, read the reconciliation to the closest GAAP measure and the stated reason for each exclusion. Compare the definition across periods. If exclusions change or recur frequently, preserve that history rather than accepting the word adjusted as proof of comparability.
Show both reported and analytical views
A transparent note presents the reported result first, then a separately labeled calculation with each adjustment. It does not erase the cost from the record or imply that the adjusted figure is audited. The point is to expose sensitivity, not manufacture a preferred answer.
A worked example
A hypothetical company reports $80 of pretax income, including a $25 gain on an asset sale and a $10 restructuring charge. Removing both items produces a separately labeled analytical result of $65 before tax.
| Step | Calculation | Pretax amount |
|---|---|---|
| Reported pretax income | Filing total | $80 |
| Remove asset-sale gain | $80 − $25 | $55 |
| Add back restructuring charge | $55 + $10 | $65 |
| Analytical result | Not a GAAP subtotal | $65 |
The example ignores tax effects and assumes the two amounts are stated on a comparable pretax basis. The $65 result is not automatically more useful than reported income. Restructuring can be a real cost of operating strategy, and asset gains can be economically relevant.
REAL-FILING PRACTICE
Separate JPMorgan's Visa gain from the reported revenue change
JPMorgan Chase & Co. · Q2 2026 Form 10-Q
Measure how much one disclosed gain contributed to the year-over-year revenue increase without presenting the remainder as an official adjusted result.
Where to look: Executive Overview; firmwide results; other-income discussion; Notes 2 and 5. Open the complete SEC filing ↗
- Record the reported comparison. Total net revenue was $57.347 billion, versus $44.912 billion a year earlier, an increase of $12.435 billion.
- Locate the unusual item. The filing identifies a $4.6 billion net gain from a Visa share exchange in Corporate and other income within noninterest revenue.
- Show the narrow calculation. Divide the gain by the reported revenue increase, and separately subtract it from current-period total net revenue.
- Preserve the rest of the filing. Credit costs, expenses, taxes, other investment gains, markets revenue, and other movements still affect the quarter and cannot be normalized by this one subtraction.
$4.6B ÷ $12.435B = about 37.0%; $57.347B − $4.6B = $52.747B as a narrowly defined illustration.
Evidence-based conclusion: The Visa gain materially enlarged the reported revenue increase, but net interest income and other noninterest components also changed.
Limit: The $52.747 billion figure is not a company-provided comparable revenue measure and does not establish recurring earnings.
Questions to take into a report
- Where is the item disclosed and is it before or after tax?
- Did it use or provide cash in this period?
- Has the company excluded similar items repeatedly?
Explore another company report → · Try your own calculator inputs →
Primary reading and preparation
Original explanation and arithmetic prepared with automated assistance from the linked primary references. Release checks cover allowed sources, citation links, numeric consistency, and prohibited advice language. Michael Delgado is accountable for corrections. Arqaris does not claim independent human, accounting, or legal review. Check the complete source filing for context. Research and educational purposes only. Not investment advice.
Report an error or unclear explanation · Read our methodology